C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 16/08 (2006.01) A61K 39/42 (2006.01) C12N 15/13 (2006.01) G01N 33/569 (2006.01) C07K 19/00 (2006.01)
Patent
CA 2672703
The present invention provides novel antibody sequences that bind human cytomegalovirus (hCMV) and neutralize hCMV infection. The novel sequences can be used for the medical management of hCMV infections, in particular for preparing pharmaceutical compositions to be used in the prophylactic or therapeutic treatment of hCMV infections.
La présente invention porte sur de nouvelles séquences d'anticorps qui se lient au cytomégalovirus humain (hCMV) et neutralisent l'infection par le hCMV. Les nouvelles séquences peuvent être utilisées pour le traitement médical des infections par le hCMV, en particulier pour préparer des compositions pharmaceutiques qui doivent être utilisées dans le traitement prophylactique ou thérapeutique des infections par le hCMV.
Funaro Ada
Gribaudo Giorgio
Landolfo Santo
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Ribovax Biotechnologies Sa
LandOfFree
Antibodies against human cytomegalovirus (hcmv) does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibodies against human cytomegalovirus (hcmv), we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies against human cytomegalovirus (hcmv) will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1620731